One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Uses of Artificial Intelligence in Nonpharmacological Rheumatology Care: What We Know, What We Need to Learn, and What Its Limitations Are
doi : 10.1002/acr.25638
Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population-Based Study, United States
doi : 10.1002/acr.25609
Development of a Personalized Visualization and Analysis Tool to Improve Clinical Care in Complex Multisystem Diseases With Application to Scleroderma
doi : 10.1002/acr.25613
Global and Regional Temporal Changes in Cross-Country Inequalities of Site-Specific Osteoarthritis Burden, 1990 to 2021
doi : 10.1002/acr.25617
Reduction in Renal Relapse and Preservation of Long-Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis
doi : 10.1002/acr.25611
Hydroxychloroquine Associated With Lower Glomerular Filtration Rate Decline in Lupus Nephritis
doi : 10.1002/acr.25616
Heterogeneity of Rheumatoid Arthritis–Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes
doi : 10.1002/acr.25620
Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial
doi : 10.1002/acr.25618
A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases
doi : 10.1002/acr.25612
Lived and Care Experiences of Chronic Musculoskeletal Shoulder Pain in Australian Adults: A Qualitative Study
doi : 10.1002/acr.25614
​Did a Non-Medical Biosimilar Switching Policy Cause an Increase in Non-Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?
doi : 10.1002/acr.25610
Statistical considerations regarding the association of higher levels of high-sensitivity C-reactive protein with future development of psoriatic arthritis in psoriasis: comment on the article by Eder et al
doi : 10.1002/acr.25633
